Endogenous ADAM10 mRNA levels and the ADAM10 promoter activities were increased on RA treatment in neuroblastoma cells: thus, retinoic acid works as an activator of the α-secretase [49-51]. Here, ADAM10 is linked to rheumatoid arthritis.